LATAM Technology Reporter
SEE OTHER BRANDS

Daily news on science and technology in Latin America

LATAM Technology Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on LATAM Technology Reporter.

Press releases published on July 30, 2025

SAIC Announces Alliance with Google Public Sector to Drive “AI at the Edge” with Google Distributed Cloud

SAIC Announces Alliance with Google Public Sector to Drive “AI at the Edge” with Google Distributed Cloud

RESTON, Va., July 30, 2025 (GLOBE NEWSWIRE) -- Science Applications International Corp. (NASDAQ: SAIC) today announced an “AI at the Edge” strategic alliance with Google Public Sector, leveraging the power of Google Distributed Cloud. This multi-year …

happn unveils AI-powered tool to redefine date planning

happn unveils AI-powered tool to redefine date planning

PARIS, July 30, 2025 (GLOBE NEWSWIRE) -- Real-life dating app happn, has launched Perfect Date — a world-first generative AI feature powered by large language models (LLMs). It helps users move from chatting to meeting-up through tailored location …

SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease

SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Combination Therapy Targeting Weight Loss and Fatty Liver Disease

TEL AVIV, Israel, July 30, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central …

Candel Therapeutics to Present at the Canaccord Genuity 45th Annual Growth Conference

Candel Therapeutics to Present at the Canaccord Genuity 45th Annual Growth Conference

NEEDHAM, Mass., July 30, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today …

IMUNON Announces First Patient Dosed in Phase 3 OVATION 3 Study of IMNN-001 in Newly Diagnosed Advanced Ovarian Cancer

IMUNON Announces First Patient Dosed in Phase 3 OVATION 3 Study of IMNN-001 in Newly Diagnosed Advanced Ovarian Cancer

Initiation of additional trial sites and patient enrollment activities ongoing with multiple patients in screening LAWRENCEVILLE, N.J., July 30, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development of its …

Retab raises $3.5M and launches most powerful document AI platform on the market

Retab raises $3.5M and launches most powerful document AI platform on the market

San Francisco, July 30, 2025 (GLOBE NEWSWIRE) -- AI agents are poised to change the world, but they can't read the documents that run it. Retab, a San Francisco-based startup founded by engineers frustrated by the broken state of document AI, is fixing …

DebitMyData Closes Oversubscribed Seed Round- Launches $1B Human Energy Grid Global Expansion

DebitMyData Closes Oversubscribed Seed Round- Launches $1B Human Energy Grid Global Expansion

DebitMyData™ Logo FORT LAUDERDALE, Fla., July 30, 2025 (GLOBE NEWSWIRE) -- DebitMyData™, Inc.—the powerhouse has closed a seed round at more than twice its original target. This surge of investor confidence paves the way for a bold, billion-dollar global …

DebitMyData השלימה סבב גיוס ראשוני עם רישום יתר - משיקה התרחבות גלובלית של Human Energy Grid בהיקף של מיליארד דולר

DebitMyData השלימה סבב גיוס ראשוני עם רישום יתר - משיקה התרחבות גלובלית של Human Energy Grid בהיקף של מיליארד דולר

לוגו DebitMyData™ פורט לודרדייל, פלורידה, July 30, 2025 (GLOBE NEWSWIRE) -- DebitMyData™, Inc - העוצמתית סגרה סבב גיוס ראשוני בסכום כפול מהיעד המקורי שלה. גל אמון זה מצד המשקיעים סולל את הדרך לפריסה עולמית נועזת, בהיקף 1 מיליארד דולר, של Human Energy Grid …

Incannex Reports Positive Topline Results from RePOSA Phase 2 Trial of IHL-42X

Incannex Reports Positive Topline Results from RePOSA Phase 2 Trial of IHL-42X

Statistically and clinically significant improvements across key clinical endpoints; IHL-42X reduced AHI by up to 83% from baseline. IHL-42X demonstrates compelling clinical benefit and an outstanding safety profile that exceeded expectations. NEW YORK and …

Shiplify Revolutionizing Revenue Retention Through Accessorial Identification Technology

Shiplify Revolutionizing Revenue Retention Through Accessorial Identification Technology

ATLANTA, July 30, 2025 (GLOBE NEWSWIRE) -- Shiplify, the primary accessorial revenue identifier for carriers, shippers and third-party logistics (3PL) providers, today introduced the first of its kind accessorial ROI calculator. This tool brings …

Kane Biotech Showcases revyve™ Preclinical and Clinical Case Study Findings at North American Wound Care Conferences

Kane Biotech Showcases revyve™ Preclinical and Clinical Case Study Findings at North American Wound Care Conferences

Clinical case series showed clinically meaningful reductions in wound size and pain, and improved tissue regranulation in chronic wound patients using revyve® over 6–12 weeks Preclinical in vitro studies demonstrated >80% reduction in protease activity, …

Corbus Pharmaceuticals Announces Upcoming Presentation of Dose Expansion Phase 1/2 Clinical Data for its Nectin-4 Targeting ADC CRB-701 at the 2025 ESMO Annual Congress

Corbus Pharmaceuticals Announces Upcoming Presentation of Dose Expansion Phase 1/2 Clinical Data for its Nectin-4 Targeting ADC CRB-701 at the 2025 ESMO Annual Congress

NORWOOD, Mass., July 30, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP), a clinical-stage company focused on oncology and obesity, announced today that an abstract on updated clinical data from its Phase 1/2 clinical study …

CPI Aerostructures Receives Follow-on Orders Totaling $2.4 Million for Welded Assemblies

CPI Aerostructures Receives Follow-on Orders Totaling $2.4 Million for Welded Assemblies

EDGEWOOD, N.Y., July 30, 2025 (GLOBE NEWSWIRE) -- CPI Aerostructures, Inc. (“CPI Aero®” or the “Company”) (NYSE American: CVU) today announced that it has received follow-on orders from multiple existing customers totaling $2.4 million to weld complex …

Skyharbour Expands Uranium Exploration Portfolio to Over 616,000 Hectares Across Thirty-Seven Projects in the Athabasca Basin, Northern Saskatchewan

Skyharbour Expands Uranium Exploration Portfolio to Over 616,000 Hectares Across Thirty-Seven Projects in the Athabasca Basin, Northern Saskatchewan

Vancouver, BC, July 30, 2025 (GLOBE NEWSWIRE) -- Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQX: SYHBF) (Frankfurt: SC1P) (“Skyharbour” or the “Company”), is pleased to announce that it has acquired, through inexpensive online staking, 21 new prospective …

Spectral AI Schedules 2025 Second Quarter Financial Results and Conference Call

Spectral AI Schedules 2025 Second Quarter Financial Results and Conference Call

DALLAS, July 30, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System and focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today …

FanDuel Sports Network Scales Live Sports Monetization with Magnite

FanDuel Sports Network Scales Live Sports Monetization with Magnite

NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) -- Magnite (NASDAQ:MGNI), the largest independent sell-side advertising company, today announced strong momentum in its collaboration with FanDuel Sports Network. The network has seen a 25% year-over-year increase …

Aventis Energy Announces Management Changes

Aventis Energy Announces Management Changes

VANCOUVER, British Columbia, July 30, 2025 (GLOBE NEWSWIRE) -- Aventis Energy (“Aventis” or the “Company”) (CSE:AVE | FRA:C0O0 | OTC: VBAMF) is pleased to announce the appointment of Michael Mulberry, current Director of Aventis, as Chief Executive Officer …

Valitor Highlights Three-fold Increase with VLTR-559 in Sustained Potency and Durability over Aflibercept in Preclinical Ocular Wet AMD Models

Valitor Highlights Three-fold Increase with VLTR-559 in Sustained Potency and Durability over Aflibercept in Preclinical Ocular Wet AMD Models

-Data showcased in session titled “Spotlight on Drug Delivery” at the Ophthalmology Innovation Source (OIS) Retina 8th Annual Innovation Summit -VLTR-559, a long-acting anti-VEGF therapy, could reduce dosing frequency for the treatment of wet AMD to twice- …

Nautilus Biotechnology Announces Agreement with the Allen Institute, Further Validating its Approach to Single-Molecule Proteomics

Nautilus Biotechnology Announces Agreement with the Allen Institute, Further Validating its Approach to Single-Molecule Proteomics

• Allen Institute to employ Iterative Mapping, Nautilus’ single-molecule proteomics method, to investigate connection between tau protein and Alzheimer’s disease • Agreement links the organizations’ next-generation proteomics technology and neuroscience …

Profusa Announces Initial $1 Million Bitcoin Investment to Initiate Its Digital Asset Treasury Strategy

Profusa Announces Initial $1 Million Bitcoin Investment to Initiate Its Digital Asset Treasury Strategy

BERKELEY, Calif, July 30, 2025 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (NASDAQ: PFSA), a commercial stage digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions